
VC funding, influencers power India's health supplements craze amid lingering safety concerns
Live Events
(You can now subscribe to our
(You can now subscribe to our Economic Times WhatsApp channel
BENGALURU/MUMBAI: A decade ago, India's health supplements mostly meant vitamin C , iron and B12 tablets purchased at pharmacies after consulting a doctor.Fast forward to 2025, and a whole new market has emerged — gummies to enhance your hair health, powders to boost collagen, liquid for gut, pills for women's perimenopause hormonal imbalance, magnesium tablets for better sleep, testosterone boosters, capsules with calming properties and vegan versions of all these.The supplements wave in the country was sparked by increased health awareness after Covid-19 pandemic and powered by social media influencer marketing and arush of venture capital (VC), according to industry executives and experts.These products are being sold directly to consumers on ecommerce websites as well as quick-commerce apps, spawning a fast-growing segment within the health sector. But as gummies and pills become lifestyle staples, the line between wellness and pseudoscience is blurring. Most items are sold over the counter—with no prescription, no pharmacist and often no clarity on whether they actually work.The result? A shelf full of products that look similar, promise big results and raise acritical question — how much of it is science, and how much social media hype?India's nutritional supplement industry, pegged at $47.92 billion in 2024, is projected to expand to $68.43 billion by 2030, at a compound annual growth rate of 8.1%, according to market research firm Research and Markets. The growth story has attracted both founders and venture capitalists. 'Just after the Covid-19 pandemic, the evolution of these nutra products happened with immunity-building items. After seeing good acceptance from the audience and more usage of digital platforms (ecommerce and quick-commerce) to buy such products, brands started experimenting with their offerings,' said Renu Bisht, founder of Commercify360, a Gurgaon-based brand consulting firm.The funding numbers back this up. According to data firm Venture Intelligence, the sector raised more than $500 million between 2020 and May 2025. The latest in the line is Mumbai-based The Good Bug , a gut health startup that raised about $12 million in a round led by Susquehanna Asia Venture Capital, with Fireside Ventures participating.Ankur Khaitan, principal at Fireside Ventures, emphasised the sharpening focus on science and research, along with innovation, in delivery formats. 'As themes like women's health, longevity and bone health evolve, we are looking to double down on startups operating at the intersection of unmet consumer needs and science-led innovation,' he said.Some health professionals are beginning to worry that the focus is shifting from effectiveness to aesthetics. 'The wellness sector is booming in India, which is why a lot of companies are getting a lot of VC funding early on.They use a lot of that funding to basically not work so much on the formulation but more on the marketability of a product,' said Poorvi Bhat Khandige, a Bengaluru-based naturopathic physician and nutritionist.'Health supplement brands are heavily reaching out to influencers because the concept is fairly new in India,' said Commercify 360's Bisht. 'Brands are partnering with health influencers, doctors and fitness trainers for marketing in order to build the audience's trust. Some brands are spending 15-30% of their budget on influencer marketing.'Ayurvedic label Kapiva , from Kolkata-based Baidyanath, works with regional wellness influencers, while nutrition brand Fast&Up aligns with athletes and fitness content creators.'We are trying to reach our target audience and continuously build awareness at the right frequency with them,' said Keshav Biyani, founder of gut health-focused brand The Good Bug. Hindustan Unilever-backed Wellbeing Nutrition, a direct-to-consumer nutraceutical player, said 20-25% of its expenses are allocated to marketing. These companies are ramping up their marketing budgets to build awareness by partnering with doctors and clinics.However, the marketing-first approach leads to many consumers buying the products without understanding them, and sometimes overusing them, leaving experts and nutritionists worried. 'We've seen almost 200% growth month-on-month where protein is concerned, which is good and bad,' said Avnish Chhabria, founder of Wellbeing Nutrition. 'It's good, because everyone's gotten the sense and understanding of what they need to take. It's bad, because even people who are eating enough protein in a day are now overconsuming it, which could eventually lead to kidney problems.' The lack of guidance regarding the usage of such products poses a real risk. In some cases, certain ingredients require specific lifestyle choices to be safe.For instance, a Jaipur-based consumer used a popular nutrition brand's metabolically lean powder for more than a year before eventually stopping, after realising that some ingredients in the product required lifestyle adjustments. 'The product has EGCG and ALA (epigallocatechin gallate and alpha-lipoic acid are ingredients typically used in weight loss products), both of which can cause issues if you-'re not active,' the person said on condition of anonymity.Additionally, some products may fall short of their promises. Hair gummies, for example, are marketed with the promise of improving hair health and making it stronger and shinier. However, according to Khandige, a nutritionist, many of these products don't contain a sufficient therapeutic dose to be truly effective.Even as the market expands, several leading brands are grappling with challenges tied to regulatory scrutiny, supply chain issues and shifting consumer expectations. GNC , a supplement retailer in the US—where the supplements market is projected to exceed $70 billion by 2031, from around $43 billion in 2022, according to data and business intelligence platform Statista—has faced multiple legal battles over product quality. Elysium Health, known for its anti-aging supplements, has drawn criticism from scientists, who have questioned the efficacy of its claims. However, the risk of such products reaching Indian consumers is heightened by the rise of fast and frictionless delivery channels such as quick-commerce apps.Most supplement products in India fall under the purview of the Food Safety and Standards Authority of India, and not the drug regulator. That means weaker scrutiny and lighter penalties despite brands making bold claims like 'improves liver health' or 'reverses aging'.Health experts have long called for stringent oversight. Recently, an interministerial committee headed by former health secretary Apurva Chandra recommended that any supplement claiming to treat or mitigate a disease should be classified as a drug. That would bring such products under the Central Drugs Standard Control Organisation and subject them to stricter regulation.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


News18
26 minutes ago
- News18
Active Covid-19 Cases Cross 5,000-Mark In India, Kerala, Delhi, Bengal Most-Affected
Last Updated: India's Covid-19 cases rise to 5,364 with 764 new cases and four deaths reported. Kerala remains the most affected state. News18 India's Covid-19 cases are on the rise again, with active infections reaching 5,364 as of Friday, according to the Union Health Ministry's latest data. In the past 24 hours, 764 new cases and four deaths have been reported. The fatalities include two in Kerala, one in Punjab, and one in Karnataka. All four patients were above 60 years of age and had co-morbidities. Since January this year, 55 deaths have been reported in the country. Kerala continues to be the most affected state, with over 1,600 active cases, followed by Gujarat, West Bengal, and Delhi. Given the rising cases, the Centre conducted mock drills to check hospital preparedness. Delhi reported 30 new Covid-19 cases, raising active infections to 592, with no new deaths since Thursday, keeping the total fatalities at seven since January 1. Maharashtra has seen a rise in Covid-19 cases, with 114 new infections reported on Friday, taking the state's total to 1,276 cases since January. Unfortunately, one more death was recorded, bringing the toll to 18. Pune (44 cases) and Mumbai (37 cases) reported the highest numbers, followed by Mira Bhayandar and Panvel with seven cases each. West Bengal reported 58 new Covid-19 cases and 91 recoveries in the last 24 hours. The total active cases now stand at 596, with the death toll remaining at one. Chhattisgarh has reported 50 new Covid-19 cases after conducting screenings in response to a surge in infections nationwide. Following the detection of a new variant, 1,183 people were tested, with a positivity rate of around 4.2%. Haryana has seen a rise in Covid-19 cases, with 31 new infections reported on Friday. Gurugram reported 9, and Faridabad 11accounting for the majority. Other cases were reported from Karnal, Jhajjar, Panipat, Yamunanagar, Hisar and Panchkula. The state currently has 87 active cases and a total of 151 cumulative cases. According to the officials, most cases are mild and managed at home. Scientists add that while Covid-19 is becoming milder, occasional surges may happen since the virus is now endemic and constantly evolving. They added that there is no cause for alarm. Hospitals nationwide conducted a mock drill to evaluate their readiness for potential Covid-19 cases on June 5, as directed by the central government. This exercise aims to ensure healthcare facilities are equipped to handle a possible surge in cases. The central government has directed all states to ensure adequate availability of oxygen, ventilators, isolation beds and essential medicines. Dr. Sunita Sharma, DGHS, chaired technical review meetings on June 2-3 with key health and disaster management agencies and state representatives. The meetings aimed to assess the current Covid-19 situation and review preparedness measures. In May 2023, the World Health Organization declared an end to Covid-19's status as a public health emergency. Today, health experts characterise the disease as seasonal, endemic, persistent, or localised to specific areas.


India Gazette
an hour ago
- India Gazette
Uttarakhand: 7 people test positive for COVID-19 in Dehradun
Dehradun (Uttarakhand) [India], June 7 (ANI): Seven people have tested positive for COVID-19 in Dehradun, taking the total number of cases in the district to 29. On Friday, three people from Rishikesh, one from Sahaspur, and three from the Raipur region were infected with coronavirus. According to the Health Department, 25 patients were tested for COVID-19 on Friday, seven of whom were reported to be positive. The health department is looking for people who came in contact with the infected patients. In view of the recent increase in COVID-19 cases in India, a series of technical review meetings were held on June 2 and 3 with various representatives under the chairpersonship of Dr Sunita Sharma, Director General of Health Services (DGHS). According to release, the representatives include Disaster Management Cell, Emergency Management Response (EMR) Cell, National Centre for Disease Control (NCDC), Indian Council of Medical Research (ICMR), Integrated Disease Surveillance Programme (IDSP) and Central Government Hospitals in Delhi and with representatives from all States and UTs to evaluate the current COVID-19 situation and preparedness measures. As of June 7, 2025, at 8 AM, India reported 5364 active COVID-19 cases. Most cases are mild and managed under home care. Since January 1, 2025, 55 deaths have been reported, primarily among individuals with pre-existing illnesses. States have been instructed to ensure the availability of oxygen, isolation beds, ventilators, and essential medicines. A mock drill assessing oxygen supply systems (PSA plants, LMO tanks, MGPS lines) was conducted on June 2. Meanwhile, Indian Institute of Technology (IIT) Guwahati researchers have developed a novel method for detecting and measuring the amount of SARS-CoV-2, the virus that causes COVID-19. The innovative approach is based on how quickly a clay-virus-electrolyte mixture settles; a process commonly known as sedimentation. The findings of this research have been published in the prestigious peer-reviewed journal, Applied Clay Science, in a paper co-authored by Prof. T V Bharat, Department of Civil Engineering, and Prof. Sachin Kumar, Department of Biosciences and Bioengineering, along with research scholars Dr Himanshu Yadav and Deepa Mehta at IIT Guwahati. (ANI)


India Gazette
an hour ago
- India Gazette
"Should also train teachers on how we can prevent COVID": Odisha Minister Nityananda Gond
Bhubaneswar (Odisha) [India], June 7 (ANI): Odisha Education Minister Nityananda Gond said the government is cautious about COVID-19 and that teachers should be trained to prevent COVID-19 infection when exposure to the virus cannot be avoided. Speaking to ANI on Friday, Minister Nityananda Gond said, '...We are cautious in this regard, and we will follow the instructions issued by the Government of India and the state government... We should also train teachers on how we can prevent COVID infection at a time when we cannot avoid exposure...' According to the Union Ministry of Health, there were 23 active COVID-19 cases in Odisha as of 8 AM on June 7. On Sunday, the number of active COVID-19 cases in the state was 12, according to the Director of Public Health, Government of Odisha, Dr Nilakantha Mishra. 'The number of cases is very low, and almost all patients diagnosed with COVID have mild symptoms. They are being treated in isolation in their own homes,' Dr Mishra told ANI. He further reassured the public, stating that the variants detected in the state are sublineages of Omicron, and there is no cause for concern at this point. 'There is nothing to worry about in Odisha. The variants that have been detected are also Omicron variants,' he added. As of June 7, 2025, at 8 AM, India reported 5364 active COVID-19 cases. Most cases are mild and managed under home care. Since January 1, 2025, 55 deaths have been reported, primarily among individuals with pre-existing illnesses. States have been instructed to ensure the availability of oxygen, isolation beds, ventilators, and essential medicines. In view of the recent increase in COVID-19 cases in India, a series of technical review meetings were held on June 2 and 3 with various representatives under the chairpersonship of Dr Sunita Sharma, Director General of Health Services (DGHS). According to a press release, the representatives include Disaster Management Cell, Emergency Management Response (EMR) Cell, National Centre for Disease Control (NCDC), Indian Council of Medical Research (ICMR), Integrated Disease Surveillance Programme (IDSP) and Central Government Hospitals in Delhi and with representatives from all States and UTs to evaluate the current COVID-19 situation and preparedness measures. (ANI)